Latest Q Capital Partners News
Mar 17, 2020
Q Capital Partners Acquires 44.68% Stake in South Korea’s Seoul Pharma for USD37m Posted On: 12 Mar 2020 |Source(s): the bell South Korea-based PE fund Q Capital Partners has acquired a 44.68% stake in pharmaceutical company Seoul Pharma for KRW45b (approximately USD37m). Read more Join today for exclusive benefits. EMPEA is the global industry association for private capital in emerging markets. Subscribers can take advantage of special offers made by EMPEA or our partner companies. Click here to sign up . In addition to these great free features, subscribers also have access to: Weekly emerging markets private capital newsletter, NewsWatch Invitations to industry events worldwide and in your market Sector- and region-specific special reports and data releases
Q Capital Partners Team
1 Team Member
Q Capital Partners has 1 team member, including current Chief Executive Officer, Eun-Sang Yoo.